Stada snaps up Sciotec and its Daosin brand

31 August 2015 - Deborah Wilkes

Archived

Germany's Stada Arzneimittel has acquired Austria's Sciotec Diagnostics Technologies, including its Daosin brand, for €17.2 million (US$19.1 million) in cash.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: